Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 11126 - 11150 of 11979 in total
TAK-243 is under investigation in clinical trial NCT03816319 (TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Refractory Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia).
Investigational
Matched Description: … TAK-243 is under investigation in clinical trial NCT03816319 (TAK-243 in Treating Patients With Relapsed …
AIM-102 is under investigation in clinical trial NCT01501942 (Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Oral Administration of AIM-102 in Patients With Mild to Moderate Allergic Asthma).
Investigational
Matched Description: … AIM-102 is under investigation in clinical trial NCT01501942 (Efficacy, Safety, Tolerability, Pharmacodynamics ... and Pharmacokinetics of Oral Administration of AIM-102 in Patients With Mild to Moderate Allergic Asthma …
Nemiralisib is under investigation in clinical trial NCT03345407 (Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)).
Investigational
Matched Description: … Nemiralisib is under investigation in clinical trial NCT03345407 (Dose Finding Study of Nemiralisib ( ... GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary …
Revaprazan is under investigation in clinical trial NCT01750437 (Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(nerd)).
Investigational
Matched Description: … Revaprazan is under investigation in clinical trial NCT01750437 (Phase 2 Clinical Trial to Investigate ... the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(nerd)). …
QR-1123 is a first-in-class investigational RNA-based oligonucleotide designed to treat autosomal dominant retinitis pigmentosa due to the P23H mutation in the rhodopsin (RHO) gene.
Investigational
Matched Description: … retinitis pigmentosa due to the P23H mutation in the rhodopsin (_RHO_) gene. ... QR-1123 is a first-in-class investigational RNA-based oligonucleotide designed to treat autosomal dominant …
Minzasolmin is under investigation in clinical trial NCT05543252 (An Extension Study to Evaluate the Long-term Efficacy, Safety and Tolerability of Minzasolmin (UCB0599) in Study Participants With Parkinson's Disease).
Investigational
Matched Description: … Minzasolmin is under investigation in clinical trial NCT05543252 (An Extension Study to Evaluate the ... Long-term Efficacy, Safety and Tolerability of Minzasolmin (UCB0599) in Study Participants With Parkinson's …
Deutarserine is under investigation in clinical trial NCT04158687 (A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With Schizophrenia).
Investigational
Matched Description: … and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With Schizophrenia). ... Deutarserine is under investigation in clinical trial NCT04158687 (A Phase 2 Study to Evaluate the Safety …
UCB7362 is an orally active plasmepsin X (PMX) inhibitor currently investigated for the treatment of malaria. Plasmepsins are aspartyl proteases produced by the malaria parasite Plasmodium falciparum, and PMX is considered to be essential for parasite egress and invasion. UCB7362 is estimated to achieve a significant reduction in asexual blood-stage...
Investigational
Matched Description: … [A254232] UCB7362 is estimated to achieve a significant reduction in asexual blood-stage parasites. ... dehydrogenase growth inhibition assay IC50 = 10 nM), and _in vivo_ (50 mg/kg dose in mice ... It has shown high potency in biochemical (IC50 = 7 nM), _in vitro_ (_P. falciparum_ 3D7 lactate …
Fimasartan is an angiotensin II receptor antagonist (ARB) drug employed in the treatment of both hypertension and heart failure. It has been found to be safe when administered with hydrochlorothiazide (a diuretic) in clinical trials. Fimasartan was initially approved September 9th, 2010 in South Korea and is marketed under the...
Investigational
Matched Description: … Fimasartan is an angiotensin II receptor antagonist (ARB) drug employed in the treatment of both hypertension ... It has been found to be safe when administered with hydrochlorothiazide (a diuretic) in clinical trials ... Fimasartan was initially approved September 9th, 2010 in South Korea and is marketed under the brand …
Decoquinate is used in veterinary to delay the growth and reproduction of coccidian parasites.
Experimental
Vet approved
Matched Description: … Decoquinate is used in veterinary to delay the growth and reproduction of coccidian parasites. …
N6022 has been used in trials studying the treatment of Asthma and Cystic Fibrosis.
Investigational
Matched Description: … N6022 has been used in trials studying the treatment of Asthma and Cystic Fibrosis. …
Balicatib has been used in trials studying the treatment of Osteoporosis and Knee Osteoarthritis.
Investigational
Matched Description: … Balicatib has been used in trials studying the treatment of Osteoporosis and Knee Osteoarthritis. …
Mk3207 has been used in trials studying the treatment of Migraine and Migraine Disorders.
Investigational
Matched Description: … Mk3207 has been used in trials studying the treatment of Migraine and Migraine Disorders. …
Acotiamide has been used in trials studying the treatment of Dyspepsia and Functional Dyspepsia.
Investigational
Matched Description: … Acotiamide has been used in trials studying the treatment of Dyspepsia and Functional Dyspepsia. …
Nona-arginine is under investigation in clinical trial NCT00264706 (PolyArginine Treated vEiN grafTs (PATENT)).
Investigational
Matched Description: … Nona-arginine is under investigation in clinical trial NCT00264706 (PolyArginine Treated vEiN grafTs …
Balaglitazone has been used in trials studying the treatment of Diabetes Mellitus, Type 2.
Investigational
Matched Description: … Balaglitazone has been used in trials studying the treatment of Diabetes Mellitus, Type 2. …
Zoliflodacin has been used in trials studying the basic science and treatment of Gonorrhoea.
Investigational
Matched Description: … Zoliflodacin has been used in trials studying the basic science and treatment of Gonorrhoea. …
Eltoprazine has been used in trials studying the treatment of Schizophrenia and Cognitive Impairment.
Investigational
Matched Description: … Eltoprazine has been used in trials studying the treatment of Schizophrenia and Cognitive Impairment. …
Granotapide has been used in trials studying the treatment of Type II Diabetes Mellitus.
Investigational
Matched Description: … Granotapide has been used in trials studying the treatment of Type II Diabetes Mellitus. …
BMS-986115 has been used in trials studying the treatment of Various Advanced Cancer.
Investigational
Matched Description: … BMS-986115 has been used in trials studying the treatment of Various Advanced Cancer. …
AZD-7687 is under investigation in clinical trial NCT01119352 (AZD7687 Multiple Ascending Dose Study).
Investigational
Matched Description: … AZD-7687 is under investigation in clinical trial NCT01119352 (AZD7687 Multiple Ascending Dose Study) …
Anfibatide is under investigation in clinical trial NCT01585259 (Anfibatide Phase Ib-IIa Clinical Trial).
Investigational
Matched Description: … Anfibatide is under investigation in clinical trial NCT01585259 (Anfibatide Phase Ib-IIa Clinical Trial …
KD7040 is a topically-delivered inducible nitric oxide synthase (iNOS) inhibitor for the treatment of neuropathic pain. The KD7040 IND was filed in 4Q06, and a Phase Ib clinical trial began 2Q07. It is being developed by Kalypsys.
Investigational
Matched Description: … The KD7040 IND was filed in 4Q06, and a Phase Ib clinical trial began 2Q07. …
A product from the iodination of MONOIODOTYROSINE. In the biosynthesis of thyroid hormones, diiodotyrosine residues are coupled with other monoiodotyrosine or diiodotyrosine residues to form T4 or T3 thyroid hormones (THYROXINE and TRIIODOTHYRONINE). [PubChem]
Experimental
Matched Description: … In the biosynthesis of thyroid hormones, diiodotyrosine residues are coupled with other monoiodotyrosine …
Marbofloxacin is a carboxylic acid, part of the third generation of antibiotic fluoroquinolones. It is used in veterinary medicine. A formulation of marbofloxacin combined with clotrimazole and dexamethasone is available under the name Aurizon.
Vet approved
Matched Description: … It is used in veterinary medicine. …
Displaying drugs 11126 - 11150 of 11979 in total